Please login to the form below

Not currently logged in
Email:
Password:

Jounce Therapeutics

This page shows the latest Jounce Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Bluebird and Celgene BCMA CAR-T kicks off ASCO

Bluebird and Celgene BCMA CAR-T kicks off ASCO

s lymphoma developed by Juno Therapeutics, which was acquired by Celgene earlier this year. ... That includes data on Jounce Therapeutics’ICOS-targeting antibody JTX-2011 which disappointed investors when the ASCO abstract was made public earlier this

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch July 2016 Deal Watch July 2016

    $240m. Bayer. X-Chem. $528m. N/A. Topping the charts this month is the $2.6bn strategic collaboration deal that Celgene signed with Jounce Therapeutics for its platform and portfolio of ... Jounce Therapeutics/ Celgene. Portfolio and platform of

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics